Daniel Kenny
Directeur des opérations chez Indsun Investments Pty Ltd.
Profil
Daniel Kenny is currently a Member of the Australian Institute of Co. Directors and the Chief Operating Officer at Indsun Investments Pty Ltd.
Previously, he worked as the Chief Executive Officer, MD & Director at OncoSil Medical Ltd.
from 2014 to 2020.
He also held positions as Vice President at Baxter BioScience Corp.
and Chief Commercial Officer & VP-Business Development at Abivax SA. Mr. Kenny obtained an undergraduate degree from the School of Mining Engineering UNSW.
Postes actifs de Daniel Kenny
Sociétés | Poste | Début |
---|---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Indsun Investments Pty Ltd.
Indsun Investments Pty Ltd. Packaged SoftwareTechnology Services Indsun Investments Pty Ltd. is a company based in Crows Nest, Australia. The Australian company's mission is to transform the landscape of health management and data utilization by strengthening health systems through an incentivized behavior change system and data capture tool developed for the immunify.life disease register. The company provides an all-in-one platform and ecosystem to capture full, transparent health records of secured patient medical information and offers the patient direct access to personal data via a unique health identification tag. The company's vision is to empower all patients and emerging economies with the tools to own and manage their health future and data to collaboratively engage in the health landscape. The company uses blockchain technology to address the world's biggest health issues by leveraging the power of big health data and artificial intelligence to ensure seamless movement of de-identified patient healthcare data. The company was founded in 2001 by Guy Newing, and Sam Bassily has been the CEO of the company since 2022. | Directeur des opérations | - |
Anciens postes connus de Daniel Kenny
Sociétés | Poste | Fin |
---|---|---|
ONCOSIL MEDICAL LIMITED | Directeur Général | 02/12/2020 |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | - |
ABIVAX | Corporate Officer/Principal | - |
Formation de Daniel Kenny
School of Mining Engineering UNSW | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABIVAX | Health Technology |
ONCOSIL MEDICAL LIMITED | Health Technology |
Entreprise privées | 3 |
---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Indsun Investments Pty Ltd.
Indsun Investments Pty Ltd. Packaged SoftwareTechnology Services Indsun Investments Pty Ltd. is a company based in Crows Nest, Australia. The Australian company's mission is to transform the landscape of health management and data utilization by strengthening health systems through an incentivized behavior change system and data capture tool developed for the immunify.life disease register. The company provides an all-in-one platform and ecosystem to capture full, transparent health records of secured patient medical information and offers the patient direct access to personal data via a unique health identification tag. The company's vision is to empower all patients and emerging economies with the tools to own and manage their health future and data to collaboratively engage in the health landscape. The company uses blockchain technology to address the world's biggest health issues by leveraging the power of big health data and artificial intelligence to ensure seamless movement of de-identified patient healthcare data. The company was founded in 2001 by Guy Newing, and Sam Bassily has been the CEO of the company since 2022. | Technology Services |